MedPath
NMPA Approval

Oxcarbazepine Oral Suspension

国药准字H20244305

June 28, 2024

Drug Information

奥卡西平口服混悬液

口服混悬剂

100ml:6g

化学药品

June 28, 2024

Company Information

Applicant Company

成都天府国际生物城(双流区乐康路9号)

Manufacturing Company

成都天府国际生物城(双流区乐康路9号)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥卡西平口服混悬液 - NMPA 批准文号 | MedPath